Featured
Anti Cancer Medicine
Dactinomycin Injection USP 0.5 mg
Price on Request
Dactinomycin Injection USP 0.5 mg is a prescription-only anticancer medicine containing Dactinomycin, a cytotoxic antineoplastic antibiotic used in the treatment of certain types of cancer. It works by binding to DNA and interfering with RNA synthesis, helping inhibit the growth and multiplication of cancer cells.
Dactinomycin is used in specialist oncology treatment protocols for conditions such as Wilms tumour, rhabdomyosarcoma, Ewing sarcoma and gestational trophoblastic neoplasia. Depending on the cancer type and treatment plan, it may be administered alone or in combination with other anticancer medicines.
Product Information:
Generic Name: Dactinomycin
Composition: Dactinomycin USP 0.5 mg
Strength: 0.5 mg per vial
Dosage Form: Injection
Therapeutic Category: Antineoplastic / Cytotoxic Antibiotic
Administration: Intravenous, under specialist supervision
Dactinomycin requires careful handling and administration by trained healthcare professionals. The dosage and treatment schedule depend on the patient's diagnosis, body size, clinical condition and prescribed chemotherapy protocol.
Important Safety Information: Dactinomycin may cause bone marrow suppression, nausea, vomiting, mouth sores and liver toxicity. Accidental leakage outside the vein can cause severe tissue damage. Appropriate monitoring and cytotoxic handling precautions are essential throughout treatment.
Dactinomycin is used in specialist oncology treatment protocols for conditions such as Wilms tumour, rhabdomyosarcoma, Ewing sarcoma and gestational trophoblastic neoplasia. Depending on the cancer type and treatment plan, it may be administered alone or in combination with other anticancer medicines.
Product Information:
Generic Name: Dactinomycin
Composition: Dactinomycin USP 0.5 mg
Strength: 0.5 mg per vial
Dosage Form: Injection
Therapeutic Category: Antineoplastic / Cytotoxic Antibiotic
Administration: Intravenous, under specialist supervision
Dactinomycin requires careful handling and administration by trained healthcare professionals. The dosage and treatment schedule depend on the patient's diagnosis, body size, clinical condition and prescribed chemotherapy protocol.
Important Safety Information: Dactinomycin may cause bone marrow suppression, nausea, vomiting, mouth sores and liver toxicity. Accidental leakage outside the vein can cause severe tissue damage. Appropriate monitoring and cytotoxic handling precautions are essential throughout treatment.
Composition
Each vial contains Dactinomycin USP 0.5 mg.
Enquire About This Product
